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Traditional diagnostic scales are based on a number of symptoms to evaluate and
classify mental diseases. In many cases, this process becomes subjective, since the
patient must calibrate the magnitude of his/her symptoms and therefore the severity
of his/her disorder. A completely different approach is based on the study of the more
vulnerable traits of cognitive disorders. In this regard, animal models of mental illness
could be a useful tool to characterize indicators of possible cognitive dysfunctions
in humans. Specifically, several cognitive disorders such as schizophrenia involve a
dysfunction in the mesocorticolimbic dopaminergic system during development. These
variations in dopamine levels or dopamine receptor sensibility correlate with many
behavioral disturbances. These behaviors may be included in a specific phenotype
and may be analyzed under controlled conditions in the laboratory. The present study
provides an introductory overview of different quantitative traits that could be used
as a possible risk indicator for different mental disorders, helping to define a specific
endophenotype. Specifically, we examine different experimental procedures to measure
impaired response in attention linked to sensorimotor gating as a possible personality
trait involved in maladaptive behaviors.
Keywords: dopamine, endophenotype, latent inhibition, mental disorder, prepulse inhibition
INTRODUCTION
The criteria used by current diagnostic scales are based on the analysis of external symptoms of
the patient. Disorders such as attention deficit with hyperactivity or mental disorders such as
schizophrenia are diagnosed based on symptoms that, in many cases, require the patient to evaluate
their intensity. This situation creates a serious problem for the diagnosis, given the large amount
of subjective information handled by the psychologist or the psychiatrist (Robbins et al., 2012).
The problem of subjectivity and comorbidity in diagnostic errors are, in part, a consequence of
the absence of biological markers to facilitate proper classification of the disorder. With relative
ease, the diagnostic manuals such as the DSM or ICD propose a continuous change in the
criteria for inclusion or exclusion of a disorder due largely to the heterogeneity and complexity
of symptoms that define that disorder. These are so complex that patients with different symptoms
might have the same diagnosis, a fact that significantly increases the difficulty of providing
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proper treatment. This high comorbidity between various
diseases indicates a clear deficiency in the classification
system of mental disorders, preventing the identification of
valid pathologies (Hyman, 2010). It is possible that the
psychotherapeutic and pharmacological failures are largely due
to this fact. Note for example that the therapeutic effectiveness of
pharmacological treatments reaches approximately 50% (Wong
et al., 2010).
Using a diverse group of pharmacological treatments to
relieve disorders such as depression is also an indicator of the
disparity of its diagnosis. For example, the use of inhibitors of
serotonin reuptake is applied for a specific type of depressive
symptoms, which differs from those used under MAO inhibitors
or under tricyclics. The differential response of each patient to
treatment indicates that disorders included in the same category
should be treated with different principles. Alternatively, this
phenomenon could be indirectly indicating that different types
of disorders within a category may have a different biological
basis.
An alternative to this traditional view is the characterisation of
endophenotypes. An endophenotype is a quantitative measurable
trait associated with a genetic predisposition (Gottesman and
Shields, 1972, 1973). In contrast to the symptomatic view of
psychopathology, the endophenotype analyses the characteristics
that show possible brain vulnerability to suffer a specific type
of disorder. The objective is the study and quantification
of specific features that reflect a mental disorder associated
with a biochemical sign (Hasler et al., 2006; Turetsky et al.,
2007). Throughout its long history, the functional study of
behavior in the laboratory has provided a number of indicators
that could serve as markers for selective expression of the
maladaptive behaviors. Applying this model to the field of
psychopathology, mental disorders could be considered as
extremes at one or both tails of these normal distributions
(Miller and Rockstroh, 2013). From this point of view,
psychopathology would view disorders as dimensional notions,
and not as categories under a binary diagnosis (Hyman,
2010; Frances and Widiger, 2012; Morris and Cuthbert,
2012).
Here, we provide a set of measurable procedures sensitive
enough to be used to identify possible endophenotypes developed
from animal models. These endophenotypes are based on the
correlation between brain processes and measurable responses
of a subject that enable us to discriminate between different sets
of symptoms, and facilitate new specific therapies. In addition,
the evaluation of these traits could facilitate a more objective
classification system of psychopathologies.
HOW DOES THE USE OF AN ANIMAL
MODEL CONTRIBUTE TO
PSYCHOPATHOLOGY CLASSIFICATION?
The recent developments in genetics and epigenetics allow
us to better approach understanding behavior and facilitate
the understanding of mental disorders. The fact that some
behaviors have a Mendelian basis, suggests the possibility of
finding simple mutations that affect behavior in a relatively
specific manner. However, there are only a small group
of features known as Mendelian traits (or traits 1:1) in
relation to genotype. Mental disorders such as depression
or schizophrenia are clearly polygenic, or may also be
generated by various mutant alleles of the same gene and
specific environmental conditions, making the analysis of
their causes a complex procedure (Zahn-Waxler et al., 1988;
Winokur and Kadrmas, 1989; Kidd, 1997; Moldin, 1997;
Owen, 2000; Torrey and Yolken, 2000; Goldman, 2012).
Moreover, these illnesses are the result of the interactions
of both genetic and epigenetic factors. And although we
now have suitable tools for genotype analysis, the fact that
these etiological factors -genes and environment- interact
to produce similar phenotypes, significantly increases the
difficulty to precisely define the specific weight of each one
in the generation of behavior (Plomin and Rende, 1991).
Identifying what groups of genes may contribute to the
expression of a disorder is a long process of molecular
genetics. However, the identification of relating groups of
genes with specific traits is currently a more achievable
goal.
The use of animal models for the study of personality traits,
vulnerability to certain disorders or substance abuse dependence
is an interesting strategy for developing behavioral protocols
in the laboratory. Although in some cases these models could
show poor face and predictive validity, the construct validity
associated with the etiology or mechanism of the underlying
disorder is usually high (O’Donnell, 2011). For example, animal
models of schizophrenia have been successful in evaluating risk
factors (see Table 1). This fact is crucial in order to develop new
pharmacological treatments or genetic therapies. However, the
reduced face validity is often a problem when applying to human
models.
The development of endophenotypes is one alternative to
try to improve this model. Taking advantage of high construct
validity, we can develop sensitive tests for quantifying specific
traits. Measures such as latent inhibition (LI) or prepulse
inhibition (PPI) are, among others, easily quantifiable under
controlled conditions in the laboratory. In addition, we can
use the advantage of these procedures in a similar way
in both animals and humans, and the results are easily
extrapolated from an animal model to a human model (Le
Pen et al., 2011). While PPI is a very simple procedure
seeking to analyze early attentional gating mechanisms, the
LI is a learning process related to selective attention and
habituation to irrelevant information (Lubow and Gewirtz,
1995; Swerdlow et al., 1996; Braff and Swerdlow, 1997).
Animal models indicate that problems in the expression of
PPI or LI correlate with cognitive deficits such as working
memory or alternation behavior, locomotion activity such as
hyperactivity induced by a dopamine receptor agonist, and
some negative symptoms also described in pathologies such
as schizophrenia (Flagstad et al., 2004; Le Pen et al., 2006;
Moore et al., 2006; Hazane et al., 2009). For example, patients
with schizophrenia show these symptoms associated with a
dysfunctional prefrontal cortex (PfC; Manoach, 2003; Silver et al.,
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TABLE 1 | Several animal models have studied schizophrenia.
MAM NVHL
Executive functions Attentional processes Flagstad et al., 2005; Featherstone et al., 2007
Working memory deficits Flagstad et al., 2005; Hazane et al., 2009 Chambers et al., 1996; Lipska et al., 2002
Perseveration Moore et al., 2006; Hazane et al., 2009 Marquis et al., 2008
Recognition deficits Featherstone et al., 2007 Sams-Dodd et al., 1997; Bachevalier et al.,
1999
Motivational behavior Increased liability for addictive
behaviors
Flagstad et al., 2005 Swerdlow et al., 2001; Brady et al., 2008
Responses to stress Le Pen et al., 2006; Hazane et al., 2009 Sams-Dodd et al., 1997
Activity Hyperlocomotion Le Pen et al., 2006; Moore et al., 2006;
Penschuck et al., 2006; Hazane et al., 2009
Lipska et al., 1993; Wan et al., 1996
Information filtering
mechanism
Sensorimotor gating deficits Le Pen et al., 2006; Moore et al., 2006; Hazane
et al., 2009
Swerdlow et al., 1995
Pharmacological models have used amphetamine, PCP or NMDA to simulate some of the symptoms. However, only two models have shown the illness as a
developmental process. The neonatal ventral hippocampal lesion (NVHL) and MAM models showed marked maladaptive behavior when animals reached adulthood.
Le Pen et al. (2011) and O’Donnell (2011) have described several behavioral procedures where we can find similar results with different techniques aimed at developing
a dysfunctional PfC.
2003; Godsil et al., 2013), therefore, a behavioral test aimed to
evaluate PfC function is a useful tool for an accurate differential
diagnostic. The knowledge acquired in recent years on the use
of a quantifiable measurement of these traits is boosting the
development of unified models of diagnosis that include data
from all levels, that is: genetics, biochemical, and behavioral
levels.
But the question is, how can we contribute to this proposal?
Consider, for instance, one of the most complex disorders,
schizophrenia. Currently, schizophrenia is an umbrella term for
a diverse group of disorders with possibly different etiologies.
Focusing on PfC dysfunction, animal research has provided
explanatory models to understand the possible development
of this mental disturbance (O’Donnell, 2011; Godsil et al.,
2013). Procedures aimed to alter gestation and fetal development
such as the MAM model (Methylazoxymethanol), or techniques
affecting the maturation process of PfC such as ventral
hippocampus lesion in neonates, allow us to experimentally
analyze this disorder (Waddington et al., 1999; Bramon et al.,
2005; Chambers and Lipska, 2011). Both procedures show
a clear PfC dysfunction (Tseng and O’Donnell, 2004, 2007).
Cells unit recording studies indicate the possibility of a deficit
in inhibitory GABAergic cells. This could be the cause of
an excessive release of dopamine cells in the mesocortical
system (Tseng and O’Donnell, 2004, 2007; O’Donnell, 2011;
Godsil et al., 2013). This could be the reason that PPI
or LI could be affected in these animal models and in
schizophrenia. Both behavioral processes require an operative
PfC for a normal expression. PPI and LI are very sensitive
to disturbances in this structure. In this regard, a deficit in
one or both processes could be a risk factor. On the whole,
the characteristics of a dysfunctional PfC and the impairment
in LI and PPI expression could be signs of a specific type
of mental disorder, apart from the current model of mental
illness where the disorder and its severity are expressed in
terms of a scale filled out by the patient or a close family
member.
DOPAMINERGIC SYSTEM AS A SIGN OF
A POSSIBLE RISK FACTOR
The function of the dopamine neurotransmitter has attracted
great interest because of its relationship with the processes of
learning and with several mental disorders such as schizophrenia,
depression, ADHT or addiction to a substance of abuse (Robbins,
1992; Feldman et al., 1997; Weiner, 2003; Grace and Sesack,
2010; Simpson et al., 2010; Wise, 2010; Milad and Rauch, 2012;
Díaz et al., 2015). The distribution of dopaminergic neurons is
abundant in the central nervous system. The midbrain neurons
and their efferences to the ventral striatum and PfC play a
special role in the learning process (Robbins and Everitt, 1996).
Dopaminergic pathways of the ventral tegmental area (VTA)
toward the nucleus accumbens (NAc) are closely linked to
the motivational processes of learning (Berridge and Robinson,
1998; Berridge, 2007). Many stimulant drugs, such as cocaine
or amphetamine, operate in this place, and their function
significantly increases the release or reduces the reuptake of
dopamine in the system.
Dopamine receptors belong to the G-protein coupled
receptors family. All these receptors possess seven
transmembrane domains and five subtypes of dopamine
receptors according to their molecular characteristics. These
have been grouped into two pharmacological families according
to the effect produced by agonists and antagonists. D1 family
includes the subtypes D1 and D5 receptors. Both stimulate
adenylyl cyclase, producing cAMP. On the other hand, D2
receptor family includes the subtypes D2, D3, and D4. These
receptors inhibit the formation of cAMP. The D1 receptor is
the most abundant in the central nervous system (Missale et al.,
1998). The greatest concentration of this receptor is found in
the neostriatum, NAc, amygdala, and substantia nigra. However,
its affinity for dopamine is relatively low. The D2 receptor is
found in high concentrations in the neostriatum (GABAergic
neurons) in the NAc and hippocampus, and with a moderate
density in the substantia nigra, cerebral cortex, globus pallidus,
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thalamus, and hypothalamus. These data make D1 and D2
receptors specific targets for the study of cognitive, emotional,
and motivational disorders. Electrophysiological studies have
made important contributions concerning their functional
activity in the mesolimbic system (O’Donnell and Grace, 1998;
Moore et al., 1999; Grace, 2000; Floresco et al., 2001; Goto and
Grace, 2008). These studies are of great relevance given the
importance of these receptors in the processes of associative
learning. Recent studies have shown that the D2 receptor is
located in the projections of both the PfC and the amygdala
in the form of autoreceptors (O’Donnell and Grace, 1995;
Groenewegen et al., 1999; Goto and Grace, 2008). Specifically, D2
receptors are located in the presynaptic areas with the function
of modulating the dopaminergic activity of the VTA over NAc
through excitatory projections. That is why this receptor has
been linked to the goal directed processes or controlled processes
that require high attentional activity (O’Donnell and Grace, 1995;
Goto and Grace, 2008). In contrast, the activity of D1 receptors
in the mesolimbic system is different than the one described
for D2. These are located in the post-synaptic cells of the NAc
that receive glutamatergic afferences from the hippocampus and
dopaminergic afferences from the VTA (O’Donnell and Grace,
1995; Groenewegen et al., 1999; Goto and Grace, 2008).
Disturbances in this system increase the risk of developing
serious mental illness (O’Donnell, 2011; Godsil et al., 2013).
Disorders such as schizophrenia have been linked directly to
disturbances during brain development associated with the
second trimester of pregnancy (Waddington et al., 1999; Bramon
et al., 2005). Changes in the dopaminergic sensitivity and in the
levels of dopamine or dopamine receptors volume could be the
result of this process. Specifically, the family of D2 receptors
seems to be more related to the disease process (Grace and Sesack,
2010; Simpson et al., 2010; Wise, 2010; Milad and Rauch, 2012),
since the antagonists of these receptors such as haloperidol are
effective in reducing symptoms (Lubow and Weiner, 2010). This
is the reason why it was suggested a substantial increase of this
type of receptors underlies this disorder as shown, for instance,
in the studies of post-mortem tissue (Seeman and Nizkik, 1990).
Currently the drug treatment of disorders such as
schizophrenia or ADHT act directly on the dopaminergic
modulation in the brain. The changes that cause the blockade
or stimulation of receptors of this neurotransmitter can be
studied in the laboratory. Changes in the sensorimotor gating
or selection of relevant stimulus of the environment can be
considered as possible quantifiable traits directly related with the
level of dopamine or dopaminergic receptors in the mesocortical
and mesolimbic system. It is important to emphasize that injuries
to PfC produce dopamine dysregulation and deficits in PPI and
LI expression.
PPI OF STARTLE RESPONSE.
A SENSORIMOTOR GATING MEASURE
The startle response to an intense stimulus is a reflex behavior
that has been described in all mammals studied. This is a
fast-twitch of the skeletal muscle that leads to processing
environmental stimuli and guiding the attention of the subject
to a possible threat. This type of response is interesting because
it has been associated with specific genes that appear in
schizophrenia and as a possible trait with endophenotypical
characteristics. For example, Vaidyanathan et al. (2014) studied
the startle blink reflex using a very large human sample.
Analyzing the startle response, they found a heritable specific
pattern of behavior in the sample. In addition, this trait
was associated with candidate genes in the endophenotype of
schizophrenia. However, although it is an automatic reaction, the
outcome can be modulated by the previous presence of a stimulus
of lower intensity, therefore PPI is defined as the attenuation
of the startle response to an intense pulse when it is preceded
by a lower-intensity prepulse stimulus. When the prepulse is
perceived, the mechanism of startle is inhibited and the animal
displays a lower response (Graham, 1975; Lüthy et al., 2003;
Larrauri and Schmajuk, 2006).
The problems with sensorimotor gating have been linked
with the levels of dopamine in the NAc. The NAc integrates
information from different structures, and even though
dopamine modulation in NAc is dependent on mesocortical
and mesolimbic systems (Ellenbroek et al., 1996; Larrauri and
Schmajuk, 2006), the selective modulation of PfC afferent
transmission is especially relevant. PfC afferences could facilitate
behaviors oriented to specific goals, and a dopamine deficit could
be involved in the incapacity to control the behavior (Goto and
Grace, 2008).
It should be noted that the dopaminergic innervation of the
PfC increases progressively through adolescence until adulthood.
In this period, we can find modifications in density, shape
and organization of the circuits (Kalsbeek et al., 1988; Benes
et al., 2000; Seamans and Yang, 2004; Segalowitz and Davies,
2004; Manitt et al., 2011; Naneix et al., 2012). A mature circuit
allows the dopaminergic neurons to fit their responses in an
adaptive way, modulating their response in correlation with
environmental changes (Spear, 2000; Tseng and O’Donnell,
2004, 2007; O’Donnell, 2011; Cass et al., 2013; Godsil et al.,
2013). Currently, it is estimated that delays or alterations in
the maturation process of the PfC dopamine system could be
the cause of a large number of mental disorders (O’Donnell,
2011; Godsil et al., 2013). Specifically, a poor inhibitory capacity
of the PfC over the NAc may be the major etiological factor
in severe disorders such as schizophrenia. In fact, a deficit in
the response to the pulse has been observed in different types
of cognitive disorders, and it is specifically relevant in patients
with schizophrenia (Braff et al., 1992, 2001a,b). Thus, a reduced
PPI could be used as a trait for attentional deficit, besides
being included as a schizotypy personality trait or a possible
endophenotype of schizophrenia (Cadenhead et al., 2000; Braff,
2010; O’Donnell, 2011).
However, this trait is not specific for patients with
schizophrenia but indicates a trait of vulnerability, and it is
very clear in patients with schizophrenia. In this regard, the
PPI deficit could be a necessary condition as a risk factor of
schizophrenia, but it could not be sufficient by itself. The PPI
deficit might be found in several disorders, and a pathological
process such as schizophrenia needs other indicators.
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PPI, DOPAMINE AND IMPULSIVITY: A
TRAIT, A NEUROTRANSMITTER AND A
QUANTIFIABLE MEASURE NOT
ASSOCIATED EXCLUSIVELY WITH
SCHIZOPHRENIA
PPI is an easy system to measure in animals including humans.
It has been used in animal models of schizophrenia, even though
there are several studies where this procedure has been correlated
with impulsivity traits. López et al. (2015) analyzed the PPI
in rats classified as impulsive by an autoshaping procedure.
Animals designated as sign trackers showed approach behavior to
a conditional stimulus before delivery of unconditional stimulus.
Specifically, for sign tracker animals (STa) the conditional
stimulus could be a surrogate of the unconditional stimulus
(Flagel et al., 2007; Robinson and Flagel, 2009). These kind of
animals showed high levels of dopamine in NAc, but only in the
presence of a conditional stimulus (Flagel et al., 2011). These data
were consistent with the results of López et al. (2015) using a
PPI procedure. In fact, the STa showed a lower PPI response to
stimuli of low intensity. This reduced inhibitory ability of the STa
showed a difference in the behavioral pattern in normal animals.
Furthermore, these data may indicate that ST subjects may be
more vulnerable to cognitive disorders in which dopamine is
involved.
An important question about the vulnerability of STa to an
impulsive behavior comes from specific activity of D2 subtype
dopamine receptor. This receptor is located presynaptically on
PfC terminals, and has been related with a selective modulation
of the NAc to facilitate goal-directed behaviors (Goto and Grace,
2008). In addition, several psychopathologies associated with PfC
have shown a deficit between this structure and the projections
to NAc (O’Donnell, 2011). López et al. (2015) found a possible
vulnerability from STa, since these animals showed a large
sensibility of D2 receptor to the administration of an agonist
such as quinpirole. This drug affected only STa performance,
indicating that this type of trait differs from that observed in
schizophrenia. It would be appropriate at this stage to point
out the difference between an animal model of impulsivity and
an animal model of schizophrenia regarding a dysfunction in
PfC. These models have developed several protocols to evaluate
attentional processes, and LI is a perfect candidate to discriminate
between impulsivity and schizophrenia, because it allows for
evaluating attention and executive functions, both specific to PfC
function. Impulsive models of animals have found differences
in incentive salience of the conditional stimulus, but not in
attentional problems (Berridge and Robinson, 1998; Berridge,
2007) such as in schizophrenia models.
LI, DOPAMINE AND ATTENTIONAL
DEFICITS
LI is a learning process observed when the acquisition of a
conditional response to a conditioned stimulus paired with a
reinforcer is retarded if the same stimulus has previously been
pre-exposed in the absence of the reinforcer. LI pharmacology
has been associated almost exclusively with the use of an animal
model of schizophrenia, and is therefore largely consistent with
the pharmacology of schizophrenia (Lubow and Kaplan, 2010;
Lubow and Weiner, 2010; Díaz et al., 2015). Specifically, because
some of the symptoms of schizophrenia are characterized by an
inability to filter, or ignore irrelevant or unimportant stimuli, an
anomalous LI was proposed as a tool for the study of possible
deficits of attention (Lubow and Weiner, 2010).
Again, dopaminergic activity of the NAc is the essential neural
substrate for its expression. Animal models have shown that the
primary role of the NAc is to restrict the expression of LI under
certain conditions, and thus ensure that the LI is flexible and
sensitive to environmental demands. It is important to highlight
that, in the absence of modulator mechanisms responsible for
restricting the expression of LI to the specific conditions, the
effects of an irrelevant stimulus would be extremely robust and
maladaptive. In this regard, LI might reflect the psychological
processes that are impaired in schizophrenia, since most of
the patients showed a reduced expression of this phenomenon.
The identification of brain regions whose damage leads to
disrupt the LI, joined with the studies of different parameters of
expression in animal models, can provide important information
on the dysfunctional brain circuits in schizophrenia. In previous
decades it was suggested that some kind of hyperactivity of the
dopaminergic systems represent a primary biochemical alteration
in schizophrenia, which apparently constituted at least a plausible
justification for biochemical alteration in this disorder (Iversen,
1976).
To gain insight into quantifiable attentional processes in
LI, Díaz et al. (2014) analyzed the effect of various types of
pre-exposure to a stimulus. The results indicated that there
is a transfer from the ventral to the dorsal striatum in the
processing of environmental information. In addition, the dorso-
medial striatum is key to encode stimuli when these become
irrelevant due to the lack of consequences after their presentation.
A deficit in PfC could be the cause of a loss of transfer from
ventral to dorsal striatum. Currently there are some laboratories
working on this possibility. The inability to modulate dopamine
in NAc does not allow for attentional disengagement, showing a
persistent state of continuous attention.
The inability of encoding irrelevant information is one of the
clearest deficits observed in patients with schizophrenia. Many
modern learning theories assume that the amount of attention to
a signal depends on how well the signal predicts the significant
event of the past. Schizophrenia is associated with attention
deficit and recent theories of psychosis have argued that positive
symptoms such as delusions and hallucinations are related
to a lack of selective attention. Patients with schizophrenia,
who had severe positive symptoms, showed a clear difficulty
in discriminating between predictive and non-predictive cues
when compared to healthy adults. In addition, the rate of
learning about non-predictive signals correlated with more severe
positive symptoms in schizophrenia. These results suggest that
the positive symptoms of schizophrenia were associated with
increased attention, both to signals that are likely to be predictive
and to those that are not predictive for causal learning. This
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selective attention deficit was the result of learning irrelevant
causal associations (Morris et al., 2013). In this regard, the
development of specific protocols to differentiate the expression
of LI could be used as a possible risk factor in the population.
However, the complexity of this disorder suggests the
possibility of different etiological factors may underlie the
disease. At present there are many contradictory results regarding
whether IL is affected in schizophrenia. Lubow and Kaplan (2010)
addressed this issue in a recent review. They emphasize the
difference between positive and negative symptoms in relation
to the expression of IL. For instance, patients with high levels of
negative symptoms and low of positive showed a potentiated LI.
This data is relevant, because they could be observing different
symptoms of the illness or different illness.
CONCLUDING REMARKS
The mesocortical input of dopamine and the PfC play a
critical role in normal cognitive processes and in several
neuropsychiatric diseases. This dopamine input regulates aspects
of working memory, planning and attention, among others.
Similarly, some disturbances may be the basis for a variety of
positive and negative symptoms, and therefore of many of the
cognitive deficits associated with mental illness. Despite intensive
research, we still have a lack of understanding of the basic
principles of dopamine activity in the PfC and all the mesolimbic
system. In recent years, there has been considerable effort to
understand the cellular mechanisms of modulation of dopamine
neurons in the PfC and its relationship with behavior. However,
the results of these efforts have often led to contradictions
and disputes (Nieoullon, 2002). Given the complexity of the
function of the mesolimbic and the dopaminergic systems,
the development of new tools will be necessary to facilitate
discrimination of diagnostics and to provide a more objective
assessment of the current classification systems. Namely, we
suggest a shift or reconsideration in diagnostic scales adding
other indicators. Clinical psychology has many tools to evaluate
PfC dysfunction (for a review see Gruszka et al., 2010). We
propose that PPI and LI could help to develop a new classification
system, where we could distinguish between a psychotic illness
such as schizophrenia by a dysfunction in PfC dopamine
from other types of schizophrenia included in current scales.
As we indicated above, current classification systems could
be considering a diverse group of disorders under the same
term of schizophrenia illness, and the different combination of
positive and negative symptoms could indicate the severity of the
disorder. The in depth analysis of these mechanisms, combined
with genetic factors, is a new view that could facilitate the
development of diagnostic categories in a more specific way and,
therefore, a new therapeutic perspective in the future.
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